Oct 17, 2022 | NEWS
CRTAC1 in plasma is a specific biomarker of osteoarthritis, a measure of OA risk, and a predictor of progression to joint replacements. The lack of a biomarker of osteoarthritis (OA) has hindered the development of effective therapies for this common disease. Kari...
Jul 20, 2022 | NEWS
Reykjavík, Iceland, July 20, 2022 – Scientists at deCODE genetics a subsidiary of Amgen together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature today. This...
May 31, 2022 | NEWS
DeCODE genetics celebrated its 25th anniversary with a two-day conference in Reykjavik on the 18 and 18th of May. The first day was dedicated to deCODES contributions to the Study of Human Diversity over 25 years. The second day was committed to Human Diversity,...
Apr 28, 2022 | NEWS
Scientists at deCODE genetics, a subsidiary of Amgen, have together with their Nordic collaborators published the largest genome-wide association study to date on rheumatoid arthritis (RA) in Annals of the Rheumatic Diseases, including over thirty thousand cases and...
Dec 2, 2021 | NEWS
In a study published today in Nature genetics, scientists at deCODE genetics, a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins in plasma at a population scale when combined with data on sequence...
Jul 19, 2021 | NEWS
Scientists from deCODE genetics have mapped 243 sequence variants affecting fetal growth, separating maternal genome and fetal genome. It sheds light on the relationships between hypertension, diabetes and fetal growth. Valgerdur Steinthorsdottir, Kari Stefansson and...
